Filing Details

Accession Number:
0001104659-18-019018
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-20 17:43:31
Reporting Period:
2018-03-16
Accepted Time:
2018-03-20 17:43:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1640266 Voyager Therapeutics Inc. VYGR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422304 Jane Henderson C/O Voyager Therapeutics
75 Sidney Street
Cambridge MA 02139
Cfo & Svp, Corp. Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-16 15,416 $11.97 15,416 No 4 M Direct
Common Stock Disposition 2018-03-16 15,416 $22.15 0 No 4 S Direct
Common Stock Acquisiton 2018-03-19 1,900 $11.97 1,900 No 4 M Direct
Common Stock Disposition 2018-03-19 1,900 $21.76 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-03-16 15,416 $0.00 15,416 $11.97
Common Stock Stock Option (Right to Buy) Disposition 2018-03-19 1,900 $0.00 1,900 $11.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
198,584 2027-01-03 No 4 M Direct
196,684 2027-01-03 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.42, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.75 to $21.80, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  3. This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. The option vests over four years, with 53,500 of the shares of common stock underlying the option vesting on 1/1/2018 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service.